USP17L12: A Drug Target / Disease Biomarker (G100287205)
USP17L12: A Drug Target / Disease Biomarker
USP17L12 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer.
One of the key functions of USP17L12 is its role in cell division. It is a transcription factor that regulates the expression of genes involved in cell growth and division, and it is thought to play a key role in the regulation of cell proliferation.
In addition to its role in cell division, USP17L12 is also involved in the regulation of cell survival. It has been shown to play a key role in the regulation of cell apoptosis, or programmed cell death, and is thought to contribute to the development of a number of diseases, including cancer.
Another function of USP17L12 is its role in tissue repair and regeneration. It is a regulator of the cell cycle, and has been shown to play a key role in the regulation of cell proliferation and differentiation in the process of tissue repair and regeneration.
In addition to its role in cell growth and repair, USP17L12 is also involved in the regulation of inflammation. It is a regulator of the immune response, and has been shown to play a key role in the regulation of inflammation and immune cell function.
Despite its widespread involvement in a number of important biological processes, USP17L12 is still an relatively well-studied protein. Only a small number of studies have directly investigated its functions, and much of its potential role in biology remains unexplored.
However, USP17L12 is an attractive target for drug development due to its involvement in a number of important biological processes. Its role in cell division, cell survival, tissue repair and regeneration, and inflammation make it a potential target for a variety of therapeutic agents, including anti-cancer drugs, anti-inflammatory drugs, and drugs that target the cell cycle.
In addition to its potential therapeutic applications, USP17L12 also has potential as a biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, and its levels have been used as a biomarker for disease diagnosis and monitoring.
Overall, USP17L12 is a protein that has broad potential as a drug target or biomarker. Further research is needed to fully understand its functions and its potential as a therapeutic agent.
Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 12
Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection
The "USP17L12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L12 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase
